Department of Laboratory, The Second Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Department of Gastroenterology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China.
Sci Rep. 2017 Mar 28;7:45176. doi: 10.1038/srep45176.
Gut-derived bacterial lipopolysaccharide (LPS) and subsequent hepatic toll-like receptor 4 (TLR4) activation have been recognized to be involved in the onset of diet-induced nonalcoholic fatty liver disease (NAFLD), but little is known about the variation of LPS and TLR4 during the progression of NAFLD. Probiotics were able to inhibit proliferation of harmful bacteria and improve gastrointestinal barrier function. However, it's unclear whether LPS/TLR4 is involved in the protection effect of probiotics on NAFLD. In this study, we described characteristic of gut microbiota structure in the progression of NAFLD, and we also analyzed the relationship between gut microbiota and LPS/TLR4 in this process. Furthermore, we applied probiotics intervention to investigate the effect of probiotics on gut flora structure, intestinal integrity, serum LPS, liver TLR4 and liver pathology. Our results showed that serum LPS and liver TLR4 were highly increased during progression of NAFLD, with gut flora diversity and gut mircobiological colonization resistance (B/E) declining. Furthermore, probiotics could improve gut microbiota structure and liver pathology. Probiotics could also downregulate serum LPS and liver TLR4. Our results suggested that both gut flora alteration and endotoxemia may be involved in the progression of NAFLD. Probiotics may delay the progression of NAFLD via LPS/TLR4 signaling.
肠道来源的细菌脂多糖(LPS)和随后的肝脏 toll 样受体 4(TLR4)激活被认为与饮食诱导的非酒精性脂肪性肝病(NAFLD)的发病有关,但关于 LPS 和 TLR4 在 NAFLD 进展过程中的变化知之甚少。益生菌能够抑制有害细菌的增殖,改善胃肠道屏障功能。然而,目前尚不清楚 LPS/TLR4 是否参与了益生菌对 NAFLD 的保护作用。在本研究中,我们描述了 NAFLD 进展过程中肠道微生物群落结构的特征,还分析了这一过程中肠道微生物群落与 LPS/TLR4 之间的关系。此外,我们应用益生菌干预来研究益生菌对肠道菌群结构、肠道完整性、血清 LPS、肝脏 TLR4 和肝脏病理的影响。我们的结果表明,在 NAFLD 进展过程中,血清 LPS 和肝脏 TLR4 显著升高,而肠道菌群多样性和肠道微生物定植抵抗力(B/E)下降。此外,益生菌可以改善肠道菌群结构和肝脏病理。益生菌还可以下调血清 LPS 和肝脏 TLR4。我们的结果表明,肠道菌群改变和内毒素血症可能都参与了 NAFLD 的进展。益生菌可能通过 LPS/TLR4 信号通路延缓 NAFLD 的进展。
Cell Physiol Biochem. 2018
JPEN J Parenter Enteral Nutr. 2013-3-28
World J Gastroenterol. 2014-6-21
World J Gastroenterol. 2014-11-14
Clin Biochem. 2015-7-4
Nutrients. 2019-11-19
Medicine (Baltimore). 2025-8-1
World J Hepatol. 2025-6-27
Biomedicines. 2025-2-6
Microorganisms. 2024-12-3
Aliment Pharmacol Ther. 2015-8-24
Biochimie. 2016-5
Biomed Res Int. 2015
World J Hepatol. 2015-6-18
Nat Rev Gastroenterol Hepatol. 2015-6-9
Atherosclerosis. 2015-1-13
Rev Recent Clin Trials. 2014